Payer+Provider's Health System Review
Fewer than half of US clinical trials have complied with the law on reporting results despite new regulations
Medtronic CEO: $1.6B Mazor Robotics acquisition is ‘beginning to pay off’
January 21, 2020
Read the full post on Becker's ASC Review
